Advertisement

Topics

Oxford BioMedica’s shares shares rise after unveiling US$100mln agreement with Bioverativ

05:00 EST 15 Feb 2018 | Proactive Investors

Oxford BioMedica will receive a US$5mln payment upfront and will be eligible to receive various milestone payments potentially worth in excess of US$100mln

Original Article: Oxford BioMedica’s shares shares rise after unveiling US$100mln agreement with Bioverativ

NEXT ARTICLE

More From BioPortfolio on "Oxford BioMedica’s shares shares rise after unveiling US$100mln agreement with Bioverativ"

Advertisement
Quick Search
Advertisement
Advertisement